Therefore, we suspected that TRIM25, as an upstream regulator of BRD7, could regulate the YB1/Bcl-2 signal axis mediated by BRD7 and participate in the malignant progression and PTX resistance of BC. The gene discussed is BCL2; the disease is breast cancer.